Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth

Overview of attention for article published in Journal of Clinical Investigation, November 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,335 followers.

Enhanced MDM4 exon6 inclusion is a widespread oncogenic mechanism and therapeutic target https://t.co/howUzFB95D

RT @jonmoulton: Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. https://t.co/BmIKjfTJhR Vivo-#Morpholino

Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. https://t.co/BmIKjfTJhR Vivo-#Morpholino

Cancer Therapy News: Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth: MDM4 is a p... https://t.co/0yevL6tG90

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.